leisure time -WSS

leisure time

author：knowledge 2025-09-30 12:10:59 - browse：816

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Be careful with at

hotspot

focus

WSS

Idaho college killings prosecutors challenge defense's grand jury claims

Judge sides with young activists in first

Hospitals are dialing back on venture capital investing

Dozens dead from Maui wildfires: What we know about the victims

Drug for rare kidney disease narrowly misses mark in clinical trial

Biden administration begins canceling student loan debt for 804,000 borrowers

hotspot

leisure time

hotspot

Medicare details structure of new drug price negotiation program

Readout LOUD podcast: possible new ALS drug, artificial wombs

State Dept. review finds Biden bears some blame for Afghanistan failures

CommonSpirit Health keeps growing, even as it loses money

Medicare details structure of new drug price negotiation program

Illumina slashes 2023 revenue projections yet again

Hollywood unions extend contract negotiations for actors

Senate HELP committee spars over health care workforce policies

Supreme Court strikes down use of affirmative action

Medical student insurance fails on mental health care coverage

Wikipedia

Lasker Awards 2023: Winners in biomedical research

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Megan Rapinoe shares emotional post following US Women's World Cup exit

Senators push IRS to launch nonprofit hospital probe

FDA panel to weigh approval of NurOwn, controversial ALS drug

Ukraine and a new approach to mental health in war

hotspot

focus

hotspot

explore